Clinical Coagulation, Malmö
251 – 260 of 662
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Epidemiological aspects of inhibitor development in hemophilia and strategies of management
- Contribution to journal › Scientific review
-
Mark
Health care resource use and costs of cancer-associated thrombosis in Sweden
- Contribution to journal › Article
- 2015
-
Mark
Severe gastrointestinal dysmotility developed after treatment with gonadotropin-releasing hormone analogs
- Contribution to journal › Article
-
Mark
Skåne Emergency Department Assessment of Patient Load (SEAL)-A Model to Estimate Crowding Based on Workload in Swedish Emergency Departments.
- Contribution to journal › Article
-
Mark
Plasminogen activator inhibitor-1 4G/5G polymorphism, factor V Leiden, prothrombin mutations and the risk of VTE recurrence.
- Contribution to journal › Article
-
Mark
Co-morbidity and mortality in Swedish patients with haemophilia - A register study
- Thesis › Doctoral thesis (compilation)
-
Mark
Studier av antidoter mot NOAK visar goda resultat.
- Contribution to journal › Article
-
Mark
Gastrointestinal symptoms among endometriosis patients -- A case-cohort study.
- Contribution to journal › Article
-
Mark
Safety and efficacy of well managed warfarin: A report from the Swedish quality register Auricula
- Contribution to journal › Article
-
Mark
Reflections on the FranceCoag report on inhibitory antibodies to factor VIII in patients with severe hemophilia A.
- Contribution to journal › Letter
